Osman Kamara

Asymptomatic infection and unrecognised Ebola virus disease in Ebola-affected households in Sierra Leone: a cross-sectional study using a new non-invasive assay for antibodies to Ebola virus

Judith R. Glynn, Hilary Bower, Sembia Johnson et al. · The Lancet Infectious Diseases · 2017 · 118 citations · Full text

Medicine, Infectious Diseases, Preventive Medicine +15

Safety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trial

David Ishola, Daniela Manno, Muhammed O. Afolabi et al. · The Lancet Infectious Diseases · 2021 · 95 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +13

Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial

Muhammed O. Afolabi, David Ishola, Daniela Manno et al. · The Lancet Infectious Diseases · 2021 · 93 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14

Exposure-Specific and Age-Specific Attack Rates for Ebola Virus Disease in Ebola-Affected Households, Sierra Leone

Hilary Bower, Sembia Johnson, Mohamed S. Bangura et al. · Emerging infectious diseases · 2016 · 57 citations · Full text

Veterinary Medicine, Infectious Diseases, Preventive Medicine +13

Deaths, late deaths, and role of infecting dose in Ebola virus disease in Sierra Leone: retrospective cohort study

Hilary Bower, Elizabeth Smout, Mohamed Bangura et al. · BMJ · 2016 · 31 citations · Full text

Veterinary Medicine, Infectious Diseases, Clinical Epidemiology +14